Annals of Surgical Oncology

, Volume 20, Issue 4, pp 1295–1301 | Cite as

Dosimetric Feasibility and Acute Toxicity in a Prospective Trial of Ultrashort-Course Accelerated Partial Breast Irradiation (APBI) Using a Multi-Lumen Balloon Brachytherapy Device

  • A. J. Khan
  • F. A. Vicini
  • S. Brown
  • B. G. Haffty
  • Thomas Kearney
  • R. Dale
  • M. Lyden
  • D. Arthur
Breast Oncology



Shorter courses of APBI, including single-fraction intraoperative therapy, are under active investigation. We designed a prospective trial to identify and address the potential radiobiological and logistical shortcomings of single-fraction APBI.


We designed a single-arm, multi-institutional, prospective phase II trial that sequentially treats 3 cohorts of women (each n = 30) with 3 progressively hypofractionated schedules. Eligible women were age ≥50 years with unifocal invasive or in situ tumors ≤3.0 cm, excised with negative margins, and with negative lymph nodes and positive hormone receptors. We defined strict dosimetric criteria for appropriateness.


A total of 30 patients were enrolled at the 7 Gy × 4 fractions dose-level and followed for 6 months. The median skin dose as a percent of prescription dose (PD) was 84 % (40–100), and the median rib dose was 71 % (16–119). Also, 95 % of the PTV_eval received a median of 95 % of PD (range 85–103). The V150 (range 14–48 cc) and V200 (range 0–29 cc) criteria were met in all cases. One breast infection occurred and was treated; 2 cases of symptomatic fat necrosis and 2 cases of symptomatic seromas occurred.


Short-course APBI is dosimetrically feasible using the Contura MLB and appears to be tolerable in terms of acute toxicities. Our approach is based on well-defined radiobiological parameters and allows for an abbreviated course of treatment that is guided by full pathological review and the ability to objectively achieve and validate acceptable dosimetric criteria in each case. We have opened enrollment to the next schedule of 8.25 Gy for 3 fractions.


  1. 1.
    Clark RM, Whelan T, Levine M, Roberts R, Willan A, McCulloch P, et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group. J Natl Cancer Inst. 1996;88:1659–64.PubMedCrossRefGoogle Scholar
  2. 2.
    Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med. 2002;347:567–75.PubMedCrossRefGoogle Scholar
  3. 3.
    Liljegren G, Holmberg L, Adami HO, Westman G, Graffman S, Bergh J. Sector resection with or without postoperative radiotherapy for stage I breast cancer: five-year results of a randomized trial. Uppsala-Orebro Breast Cancer Study Group. J Natl Cancer Inst. 1994;86:717–22.PubMedCrossRefGoogle Scholar
  4. 4.
    Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227–32.PubMedCrossRefGoogle Scholar
  5. 5.
    Clark RM, McCulloch PB, Levine MN, Lipa M, Wilkinson RH, Mahoney LJ, et al. Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst. 1992;84:683–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Arthur DW, Koo D, Zwicker RD, Tong S, Bear HD, Kaplan BJ, et al. Partial breast brachytherapy after lumpectomy: low-dose-rate and high-dose-rate experience. Int J Radiat Oncol Biol Phys. 2003;56:681–9.PubMedCrossRefGoogle Scholar
  7. 7.
    Arthur DW, Vicini FA. Accelerated partial breast irradiation as a part of breast conservation therapy. J Clin Oncol. 2005;23:1726–35.PubMedCrossRefGoogle Scholar
  8. 8.
    Vicini FA, Kestin L, Chen P, Benitez P, Goldstein NS, Martinez A. Limited-field radiation therapy in the management of early-stage breast cancer. J Natl Cancer Inst. 2003;95:1205–10.PubMedCrossRefGoogle Scholar
  9. 9.
    Chen PY, Vicini FA, Benitez P, Kestin LL, Wallace M, Mitchell C, et al. Long-term cosmetic results and toxicity after accelerated partial-breast irradiation: a method of radiation delivery by interstitial brachytherapy for the treatment of early-stage breast carcinoma. Cancer. 2006;106:991–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Chen PY, Wallace M, Mitchell C, Grills I, Kestin L, Fowler A, et al. Four-year efficacy, cosmesis, and toxicity using three-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2010;76:991–7.PubMedCrossRefGoogle Scholar
  11. 11.
    Vicini FA, Chen P, Wallace M, Mitchell C, Hasan Y, Grills I, et al. Interim cosmetic results and toxicity using 3D conformal external beam radiotherapy to deliver accelerated partial breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2007;69:1124–30.PubMedCrossRefGoogle Scholar
  12. 12.
    Goyal S, Khan AJ, Vicini F, Beitsch PD, Lyden M, Keisch M, et al. Factors associated with optimal cosmetic results at 36 months in patients treated with accelerated partial breast irradiation (APBI) on the American Society of Breast Surgeons (ASBrS) MammoSite Breast Brachytherapy Registry Trial. Ann Surg Oncol. 2009;16:2450–8.PubMedCrossRefGoogle Scholar
  13. 13.
    Khan AJ, Vicini F, Beitsch P, Haffty B, Quiet C, Keleher A, et al. Local control, toxicity, and cosmesis in women younger than 50 enrolled onto the American Society of Breast Surgeons MammoSite Radiation Therapy System registry trial. Ann Surg Oncol. 2009;16:1612–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Smith BD, Arthur DW, Buchholz TA, Haffty BG, Hahn CA, Hardenbergh PH, et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). J Am Coll Surg. 2009;209:269–77.PubMedCrossRefGoogle Scholar
  15. 15.
    Vaidya JS, Joseph DJ, Tobias JS, Bulsara M, Wenz F, Saunders C, et al. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet. 2010;376:91–102.PubMedCrossRefGoogle Scholar
  16. 16.
    Reitsamer R, Fastner G, Kopp M, Menzel C, Sedlmayer F. Intraoperative radiotherapy for early breast cancer. Lancet. 2010;376:1141; author reply 1143–4.Google Scholar
  17. 17.
    Smith BD, Buchholz TA, Kuerer HM. Intraoperative radiotherapy for early breast cancer. Lancet. 2010;376:1141; author reply 1143–4.Google Scholar
  18. 18.
    Haviland JS, A’Hern R, Bliss JM. Intraoperative radiotherapy for early breast cancer. Lancet. 2010;376:1142; author reply 1143–4.Google Scholar
  19. 19.
    Cameron D, Kunkler I, Dixon M, Jack W, Thomas J, Kerr G. Intraoperative radiotherapy for early breast cancer. Lancet. 2010;376:1142; author reply 1143–4.Google Scholar
  20. 20.
    Azria D, Bourgier C. Partial breast irradiation: new standard for selected patients. Lancet. 2010;376:71–2.PubMedCrossRefGoogle Scholar
  21. 21.
    Sautter-Bihl ML, Sedlmayer F, Budach W, Dunst J, Engenhart-Cabillic R, Fietkau R, et al. Intraoperative radiotherapy as accelerated partial breast irradiation for early breast cancer : beware of one-stop shops? Strahlenther Onkol. 2010;186:651–7.PubMedCrossRefGoogle Scholar
  22. 22.
    Vaidya JS, Tobias JS, Baum M, Wenz F, Kraus-Tiefenbacher U, D’souza D, et al. TARGeted Intraoperative radiotherapy (TARGIT): an innovative approach to partial-breast irradiation. Semin Radiat Oncol. 2005;15:84–91.PubMedCrossRefGoogle Scholar
  23. 23.
    Veronesi U, Gatti G, Luini A, Intra M, Ciocca M, Sanchez D, et al. Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery. Arch Surg. 2003;138:1253–6.PubMedCrossRefGoogle Scholar
  24. 24.
    Veronesi U, Orecchia R, Luini A, Galimberti V, Zurrida S, Intra M, et al. Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electrons. Breast Cancer Res Treat. 2010;124:141–51.PubMedCrossRefGoogle Scholar
  25. 25.
    Orecchia R, Ciocca M, Lazzari R, Garibaldi C, Leonardi MC, Luini A, et al. Intraoperative radiation therapy with electrons (ELIOT) in early-stage breast cancer. Breast. 2003;12:483–90.PubMedCrossRefGoogle Scholar
  26. 26.
    Beal K, McCormick B, Zelefsky MJ, Borgen P, Fey J, Goldberg J, et al. Single-fraction intraoperative radiotherapy for breast cancer: early cosmetic results. Int J Radiat Oncol Biol Phys. 2007;69:19–24.PubMedCrossRefGoogle Scholar
  27. 27.
    Wallace M, Martinez A, Mitchell C, Chen PY, Ghilezan M, Benitez P, et al. Phase I/II study evaluating early tolerance in breast cancer patients undergoing accelerated partial breast irradiation treated with the mammosite balloon breast brachytherapy catheter using a 2-day dose schedule. Int J Radiat Oncol Biol Phys. 2010;77:531–6.PubMedCrossRefGoogle Scholar
  28. 28.
    Sacchini V, Beal K, Goldberg J, Montgomery L, Port E, McCormick B. Study of quadrant high-dose intraoperative radiation therapy for early-stage breast cancer. Br J Surg. 2008;95:1105–10.PubMedCrossRefGoogle Scholar
  29. 29.
    Owen JR, Ashton A, Bliss JM, Homewood J, Harper C, Hanson J, et al. Effect of radiotherapy fraction size on tumor control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncol. 2006;7:467–71.PubMedCrossRefGoogle Scholar
  30. 30.
    Wyatt R, Jones B, Dale R. Radiotherapy treatment delays and their influence on tumour control achieved by various fractionation schedules. Br J Radiol. 2008;81:549–63.PubMedCrossRefGoogle Scholar
  31. 31.
    Dale R, Coles I, Deehan C, O’Donoghue J. Calculation of integrated biological response in brachytherapy. Int J Radiat Oncol Biol Phys. 1997;38:633–42.PubMedCrossRefGoogle Scholar
  32. 32.
    Formenti S, Gidea-Addeo D, Goldberg J, Roses DF, Guth A, Rosenstein BS, et al. Phase I-II trial of prone accelerated intensity modulated radiation therapy to the breast to optimally spare normal tissue. J Clin Oncol. 2007;25:2236–42.PubMedCrossRefGoogle Scholar
  33. 33.
    Wilkinson JB, Martinez AA, Chen PY, Ghilezan MI, Wallace MF, Grills IS, et al. Four-year results using balloon-based brachytherapy to deliver accelerated partial breast irradiation with a 2-day dose fractionation schedule. Brachytherapy. 2012;11:97–104.PubMedCrossRefGoogle Scholar
  34. 34.
    Wazer DE, Kaufman S, Cuttino L, DiPetrillo T, Arthur DW. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy. Int J Radiat Oncol Biol Phys. 2006;64:489–95.PubMedCrossRefGoogle Scholar
  35. 35.
    Hattangadi JA, Powell SN, Macdonald SM, Mauceri T, Ancukiewicz M, Freer P, et al. Accelerated partial breast irradiation with low-dose-rate interstitial implant brachytherapy after wide local excision: 12-year outcomes from a prospective trial. Int J Radiat Oncol Biol Phys. 2012;83:791-800.PubMedGoogle Scholar

Copyright information

© Society of Surgical Oncology 2012

Authors and Affiliations

  • A. J. Khan
    • 1
  • F. A. Vicini
    • 2
  • S. Brown
    • 3
  • B. G. Haffty
    • 1
  • Thomas Kearney
    • 1
  • R. Dale
    • 4
  • M. Lyden
    • 5
  • D. Arthur
    • 6
  1. 1.Robert Wood Johnson University Hospital/Cancer Institute of New JerseyNew BrunswickUSA
  2. 2.Michigan HealthCare Professionals/21st Century OncologyFarmington HillsUSA
  3. 3.Wellstar Kennestone HospitalMariettaUSA
  4. 4.Imperial CollegeLondonUK
  5. 5.BioStat International, IncTampaUSA
  6. 6.Massey Cancer CenterVirginia Commonwealth UniversityRichmondUSA

Personalised recommendations